205 related articles for article (PubMed ID: 35580931)
1. Mitoribosomal defects aggravate liver cancer via aberrant glycolytic flux and T cell exhaustion.
Song BS; Moon JS; Tian J; Lee HY; Sim BC; Kim SH; Kang SG; Kim JT; Nga HT; Benfeitas R; Kim Y; Park S; Wolfe RR; Eun HS; Shong M; Lee S; Kim IY; Yi HS
J Immunother Cancer; 2022 May; 10(5):. PubMed ID: 35580931
[TBL] [Abstract][Full Text] [Related]
2. Lactate-mediated mitoribosomal defects impair mitochondrial oxidative phosphorylation and promote hepatoma cell invasiveness.
Lee YK; Lim JJ; Jeoun UW; Min S; Lee EB; Kwon SM; Lee C; Yoon G
J Biol Chem; 2017 Dec; 292(49):20208-20217. PubMed ID: 28978646
[TBL] [Abstract][Full Text] [Related]
3. CRIF1 overexpression facilitates tumor growth and metastasis through inducing ROS/NFκB pathway in hepatocellular carcinoma.
Chang H; Li J; Qu K; Wan Y; Liu S; Zheng W; Zhang Z; Liu C
Cell Death Dis; 2020 May; 11(5):332. PubMed ID: 32382077
[TBL] [Abstract][Full Text] [Related]
4. Mitochondrial Metabolic Signatures in Hepatocellular Carcinoma.
Lee HY; Nga HT; Tian J; Yi HS
Cells; 2021 Jul; 10(8):. PubMed ID: 34440674
[TBL] [Abstract][Full Text] [Related]
5. A novel spontaneous hepatocellular carcinoma mouse model for studying T-cell exhaustion in the tumor microenvironment.
Liu YT; Tseng TC; Soong RS; Peng CY; Cheng YH; Huang SF; Chuang TH; Kao JH; Huang LR
J Immunother Cancer; 2018 Dec; 6(1):144. PubMed ID: 30526672
[TBL] [Abstract][Full Text] [Related]
6. Expression, immune infiltration and clinical significance of SPAG5 in hepatocellular carcinoma: A gene expression-based study.
Chen W; Chen X; Li S; Ren B
J Gene Med; 2020 Apr; 22(4):e3155. PubMed ID: 31860771
[TBL] [Abstract][Full Text] [Related]
7. ATR inhibitor AZD6738 enhances the antitumor activity of radiotherapy and immune checkpoint inhibitors by potentiating the tumor immune microenvironment in hepatocellular carcinoma.
Sheng H; Huang Y; Xiao Y; Zhu Z; Shen M; Zhou P; Guo Z; Wang J; Wang H; Dai W; Zhang W; Sun J; Cao C
J Immunother Cancer; 2020 May; 8(1):. PubMed ID: 32461345
[TBL] [Abstract][Full Text] [Related]
8. Single-cell RNA-sequencing atlas reveals an FABP1-dependent immunosuppressive environment in hepatocellular carcinoma.
Tang W; Sun G; Ji GW; Feng T; Zhang Q; Cao H; Wu W; Zhang X; Liu C; Liu H; Huang T; Liu L; Xia Y; Wang X
J Immunother Cancer; 2023 Nov; 11(11):. PubMed ID: 38007237
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-35 has a tumor-promoting role in hepatocellular carcinoma.
Liu X; Ren H; Guo H; Wang W; Zhao N
Clin Exp Immunol; 2021 Feb; 203(2):219-229. PubMed ID: 33030251
[TBL] [Abstract][Full Text] [Related]
10. Glycolytic activation of peritumoral monocytes fosters immune privilege via the PFKFB3-PD-L1 axis in human hepatocellular carcinoma.
Chen DP; Ning WR; Jiang ZZ; Peng ZP; Zhu LY; Zhuang SM; Kuang DM; Zheng L; Wu Y
J Hepatol; 2019 Aug; 71(2):333-343. PubMed ID: 31071366
[TBL] [Abstract][Full Text] [Related]
11. 2,5-dimethylcelecoxib alleviated NK and T-cell exhaustion in hepatocellular carcinoma via the gastrointestinal microbiota-AMPK-mTOR axis.
Pan B; Chen Z; Zhang X; Wang Z; Yao Y; Wu X; Qiu J; Lin H; Yu L; Tu H; Tang N
J Immunother Cancer; 2023 Jun; 11(6):. PubMed ID: 37316264
[TBL] [Abstract][Full Text] [Related]
12. TOX promotes the exhaustion of antitumor CD8
Wang X; He Q; Shen H; Xia A; Tian W; Yu W; Sun B
J Hepatol; 2019 Oct; 71(4):731-741. PubMed ID: 31173813
[TBL] [Abstract][Full Text] [Related]
13. MRPS31 loss is a key driver of mitochondrial deregulation and hepatocellular carcinoma aggressiveness.
Min S; Lee YK; Hong J; Park TJ; Woo HG; Kwon SM; Yoon G
Cell Death Dis; 2021 Nov; 12(11):1076. PubMed ID: 34772924
[TBL] [Abstract][Full Text] [Related]
14. Identification of immunological subtypes of hepatocellular carcinoma with expression profiling of immune-modulating genes.
Cao D; Chen MK; Zhang QF; Zhou YF; Zhang MY; Mai SJ; Zhang YJ; Chen MS; Li XX; Wang HY
Aging (Albany NY); 2020 Jun; 12(12):12187-12205. PubMed ID: 32544882
[TBL] [Abstract][Full Text] [Related]
15. CR6-Interacting Factor 1 Deficiency Impairs Vascular Function by Inhibiting the Sirt1-Endothelial Nitric Oxide Synthase Pathway.
Nagar H; Jung SB; Ryu MJ; Choi SJ; Piao S; Song HJ; Kang SK; Shin N; Kim DW; Jin SA; Jeong JO; Irani K; Jeon BH; Shong M; Kweon GR; Kim CS
Antioxid Redox Signal; 2017 Aug; 27(4):234-249. PubMed ID: 28117598
[TBL] [Abstract][Full Text] [Related]
16. Disruption of SIRT7 Increases the Efficacy of Checkpoint Inhibitor via MEF2D Regulation of Programmed Cell Death 1 Ligand 1 in Hepatocellular Carcinoma Cells.
Xiang J; Zhang N; Sun H; Su L; Zhang C; Xu H; Feng J; Wang M; Chen J; Liu L; Shan J; Shen J; Yang Z; Wang G; Zhou H; Prieto J; Ávila MA; Liu C; Qian C
Gastroenterology; 2020 Feb; 158(3):664-678.e24. PubMed ID: 31678303
[TBL] [Abstract][Full Text] [Related]
17. Role of DTL in Hepatocellular Carcinoma and Its Impact on the Tumor Microenvironment.
Li Z; Wang R; Qiu C; Cao C; Zhang J; Ge J; Shi Y
Front Immunol; 2022; 13():834606. PubMed ID: 35392073
[TBL] [Abstract][Full Text] [Related]
18. Targeting adenosinergic pathway enhances the anti-tumor efficacy of sorafenib in hepatocellular carcinoma.
Liao J; Zeng DN; Li JZ; Hua QM; Xiao Z; He C; Mao K; Zhu LY; Chu Y; Wen WP; Zheng L; Wu Y
Hepatol Int; 2020 Jan; 14(1):80-95. PubMed ID: 31802389
[TBL] [Abstract][Full Text] [Related]
19. Mitoribosome insufficiency in β cells is associated with type 2 diabetes-like islet failure.
Hong HJ; Joung KH; Kim YK; Choi MJ; Kang SG; Kim JT; Kang YE; Chang JY; Moon JH; Jun S; Ro HJ; Lee Y; Kim H; Park JH; Kang BE; Jo Y; Choi H; Ryu D; Lee CH; Kim H; Park KS; Kim HJ; Shong M
Exp Mol Med; 2022 Jul; 54(7):932-945. PubMed ID: 35804190
[TBL] [Abstract][Full Text] [Related]
20. PD1
Ma J; Zheng B; Goswami S; Meng L; Zhang D; Cao C; Li T; Zhu F; Ma L; Zhang Z; Zhang S; Duan M; Chen Q; Gao Q; Zhang X
J Immunother Cancer; 2019 Nov; 7(1):331. PubMed ID: 31783783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
